Did Viking Therapeutics Just Say "Checkmate" To Eli Lilly? [Yahoo! Finance]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Yahoo! Finance
In addition to the unprecedented growth of its diabetes and obesity care treatments, Lilly has also secured some major wins from the Food and Drug Administration (FDA), including approval for both its Alzheimer's disease candidate and eczema drug While it looks like Lilly may be entering yet a new growth period, there's a lingering competitive threat looming in the background -- and I'm not talking about Novo Nordisk Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every market day. Sign Up For Free » Viking Therapeutics (NASDAQ: VKTX) is a clinical-stage pharma company that's been eyeing the weight loss market for some time now. During its third-quarter earnings call a few weeks ago, Viking's management revealed some interesting information -- and if I were an executive at Lilly, I'd be listening closely. Below, I'll break down what's going on at Viking and explain how the company may emerge as a competitive force in the weight loss realm. Right now, V
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- Viking Therapeutics, Inc. (NASDAQ: VKTX) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $102.00 price target on the stock.MarketBeat
- Why Viking Therapeutics Inc. (VKTX) Went Down on Monday [Yahoo! Finance]Yahoo! Finance
- 2 Stocks to Buy With Less Than $40 [Yahoo! Finance]Yahoo! Finance
- 2 Stocks That Could Soar Again in 2025 [Yahoo! Finance]Yahoo! Finance
- Down 65%, Is Viking Therapeutics Stock a Buy on the Dip? [Yahoo! Finance]Yahoo! Finance
VKTX
Earnings
- 2/5/25 - Miss
VKTX
Sec Filings
- 2/5/25 - Form 8-K
- 2/4/25 - Form SCHEDULE
- 1/6/25 - Form 4
- VKTX's page on the SEC website